cannabis indica

Índice completo — página 73 de 77

Estudos 7.201 a 7.300 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2003 a 2001. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 7.201 a 7.300

  1. 2003

    Antileukemic activity of selected natural products in Taiwan.

    FavorávelEstudo LaboratorialCâncerCâncer — LeucemiaCâncer — Linfoma
  2. 2003

    Antitumor activity of balsam fir oil: production of reactive oxygen species induced by alpha-humulene as possible mechanism of action.

    FavorávelEstudo LaboratorialCâncer
  3. 2003

    Behavioral and subjective effects of marijuana following partial sleep deprivation

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisInsônia e Distúrbios do Sono
  4. 2003

    Cannabinoid CB2 Receptors And Fatty Acid Amide Hydrolase Are Selectively Overexpressed In Neuritic Plaque-associated Glia In Alzheimer's Disease Brains

    FavorávelEstudo LaboratorialDoença de AlzheimerHidrolase de Amidas de Ácidos Graxos (FAAH)
  5. 2003

    Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716

    FavorávelEstudo em AnimaisPerda de ApetiteAnandamida (AEA)Tetraidrocanabinol (THC)+2
  6. 2003

    Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

    InconclusivoEnsaio Clínico Duplo-CegoDoenças NeurodegenerativasEsclerose Múltipla
  7. 2003

    Cannabis and alcohol--a close friendship

    InconclusivoMetanáliseDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+1
  8. 2003

    Cannabis Reduces Opioid Dose in the Treatment of Chronic Non-Cancer Pain.

    FavorávelMetanáliseDorDor — CrônicaTetraidrocanabinol (THC)
  9. 2003

    Cannabis Use as Described by People with Multiple Sclerosis.

    FavorávelMetanáliseEsclerose Múltipla
  10. 2003

    CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaTetraidrocanabinol (THC)Endocanabinoide (não especificado)+6
  11. 2003

    Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder

    DesfavorávelEnsaio ClínicoDependência QuímicaPsicose
  12. 2003

    Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

    FavorávelMetanáliseNáusea e VômitoÁcido Canabidiólico (CBD-a)
  13. 2003

    Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

    FavorávelMetanáliseNáusea e VômitoNáusea e Vômito por QuimioterapiaEnjoo Matinal na GestaçãoÁcido Canabidiólico (CBD-a)+1
  14. 2003

    Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice

    InconclusivoEstudo em AnimaisDependência QuímicaDependência — ÁlcoolEndocanabinoide (não especificado)
  15. 2003

    Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial

    FavorávelEnsaio Clínico Duplo-CegoTiques e Síndrome de Tourette
  16. 2003

    Drug-induced Hypothermia Reduces Ischemic Damage: Effects of the Cannabinoid HU-210

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)EpilepsiaEstresse OxidativoCanabinoides Sintéticos HU-x+3
  17. 2003

    Effect of D-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults

    FavorávelEnsaio Clínico Duplo-CegoInsônia e Distúrbios do SonoTetraidrocanabinol (THC)
  18. 2003

    Effects of Cannabidiol (CBD) on Regional Cerebral Blood Flow

    FavorávelEnsaio Clínico Duplo-CegoAnsiedade
  19. 2003

    Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate.

    FavorávelEstudo em AnimaisDoença de HuntingtonTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  20. 2003

    Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior

    InconclusivoEstudo em AnimaisGestaçãoAlterações Cerebrais Neonatais
  21. 2003

    Efficacy of two cannabis‐based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

    FavorávelEnsaio Clínico Duplo-CegoDorDor — AgudaDor — Síndrome da Dor CentralTetraidrocanabinol (THC)THC:CBD Farmacêutico+1
  22. 2003

    Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice

    FavorávelEstudo em AnimaisCondições GeriátricasLongevidadeCanabinoides Sintéticos SR-x
  23. 2003

    Endocannabinoids as autoregulatory signaling molecules: coupling to nitric oxide and a possible association with the relaxation response

    FavorávelMetanáliseAnandamida (AEA)Endocanabinoide (não especificado)+1
  24. 2003

    Established and potential therapeutic applications of cannabinoids in oncology.

    FavorávelMetanáliseNáusea e VômitoAnorexia (perda de apetite)THC Farmacêutico
  25. 2003

    Exercise activates the endocannabinoid system

    FavorávelMetanáliseDorDor — AgudaEndocanabinoide (não especificado)Exercício Físico
  26. 2003

    High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma

    InconclusivoEstudo LaboratorialCâncerCâncer — Linfoma
  27. 2003

    Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin

    DesfavorávelEnsaio ClínicoDermatite de Contato AlérgicaCanabinoides Sintéticos HU-x
  28. 2003

    Inhibition of acetylcholine-mediated effects by borneol

    FavorávelEstudo LaboratorialDorDor — Aguda
  29. 2003

    Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation.

    FavorávelEstudo em AnimaisTosseCanabinoides Sintéticos SR-xCanabinoides Sintéticos JWH-x
  30. 2003

    Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.

    FavorávelEstudo em AnimaisCâncerCâncer — Pele (não melanoma)Canabinoides Sintéticos WIN-xCanabinoides Sintéticos SR-x+1
  31. 2003

    Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis

    FavorávelEstudo em AnimaisCâncerCâncer — TireoideAnandamida (AEA)
  32. 2003

    International Association for Cannabis as Medicine.

    FavorávelMetanáliseEpilepsia
  33. 2003

    Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain.

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — AgudaTetraidrocanabinol (THC)
  34. 2003

    Modulation of anxiety through blockade of anandamide hydrolysis

    FavorávelEstudo em AnimaisAnsiedadeHidrolase de Amidas de Ácidos Graxos (FAAH)
  35. 2003

    Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Opioides
  36. 2003

    Neuroprotective Effect of(−)Δ9-Tetrahydrocannabinol and Cannabidiol in N-Methyl-d-Aspartate-Induced Retinal Neurotoxicity

    FavorávelEstudo em AnimaisGlaucomaCanabinoides Sintéticos SR-x
  37. 2003

    Perinatal exposure to delta 9-tetrahydrocannabinol increases presynaptic dopamine D2 receptor sensitivity: a behavioral study in rats

    DesfavorávelEstudo em AnimaisGestaçãoAlterações Cerebrais Neonatais
  38. 2003

    Sensitization of Staphylococcus aureus and Escherichia coli to Antibiotics by the Sesquiterpenoids Nerolidol, Farnesol, Bisabolol, and Apritone.

    FavorávelEstudo LaboratorialInfecção por Estafilococos
  39. 2003

    Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial

    FavorávelEnsaio Clínico Duplo-CegoHIV/AIDSTHC Farmacêutico
  40. 2003

    Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols

    InconclusivoEstudo em AnimaisDelta-8-THC
  41. 2003

    The endocannabinoid system and Huntington's disease.

    FavorávelMetanáliseDoença de HuntingtonEndocanabinoide (não especificado)Canabinoide Sintético (não especificado)
  42. 2003

    The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation

    FavorávelEstudo LaboratorialCâncerCâncer — Leucemia2-Araquidonoilglicerol (2-AG)Canabinoides Sintéticos SR-x
  43. 2003

    Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance

    FavorávelEnsaio Clínico Duplo-CegoTiques e Síndrome de TouretteTetraidrocanabinol (THC)
  44. 2003

    Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats

    FavorávelEstudo em AnimaisLesões da Medula EspinhalCanabinoides Sintéticos WIN-x
  45. 2002

    A Dramatic Response to Inhaled Cannabis in a Woman with Central Thalamic Pain and Dystonia

    FavorávelMetanáliseDorDistoniaDor — Síndrome da Dor Central
  46. 2002

    A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

    FavorávelEstudo em AnimaisAnorexia (perda de apetite)Anandamida (AEA)Endocanabinoide (não especificado)
  47. 2002

    Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.

    FavorávelEstudo em AnimaisDoença de HuntingtonAnandamida (AEA)Canabinoides Sintéticos AM-x
  48. 2002

    Anandamide And Noladin Ether Prevent Neurotoxicity Of The Human Amyloid-beta Peptide

    FavorávelEstudo LaboratorialDoença de AlzheimerAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  49. 2002

    Attenuation Of Spontaneous Opiate Withdrawal In Mice By The Anandamide Transport Inhibitor AM404

    FavorávelEstudo em AnimaisDependência QuímicaDependência — OpioidesAnandamida (AEA)
  50. 2002

    Brain monoglyceride lipase participating in endocannabinoid inactivation

    InconclusivoEstudo Laboratorial2-Araquidonoilglicerol (2-AG)Monoacilglicerol Lipase (MAGL)
  51. 2002

    Cannabidiol: an overview of some pharmacological aspects

    FavorávelMetanáliseAnsiedadeEpilepsiaPsicoseAnandamida (AEA)+5
  52. 2002

    Cannabinoid CB(1) receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat

    FavorávelEstudo em AnimaisChoque HemorrágicoCanabinoides Sintéticos SR-x
  53. 2002

    Cannabinoid Receptor Agonism Inhibits Transient Lower Esophageal Sphincter Relaxations and Reflux in Dogs

    FavorávelEstudo em AnimaisAplicações VeterináriasRefluxo GastroesofágicoCanabinoides Sintéticos WIN-xCanabinoides Sintéticos SR-x
  54. 2002

    Cannabinoids and brain injury: therapeutic implications

    FavorávelMetanáliseTraumatismo CranioencefálicoAnandamida (AEA)Endocanabinoide (não especificado)+2
  55. 2002

    Cannabis Treatments in Obstetrics and Gynecology: A Historical Review

    FavorávelMetanáliseDistúrbios Menstruais
  56. 2002

    Central Effects of Citral, Myrcene and Limonene, Constituents of Essential Oil Chemotypes From Lippia Alba (Mill.) n.e. Brown

    FavorávelEstudo em AnimaisAnsiedadeInsônia e Distúrbios do SonoMedicina Mente-Corpo
  57. 2002

    Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

    FavorávelEstudo LaboratorialVirodamina (O-AEA)
  58. 2002

    Crack Heads and Roots Daughters: The Therapeutic Use of Cannabis in Jamaica

    FavorávelMetanáliseDependência QuímicaDependência — Cocaína
  59. 2002

    Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration

    DesfavorávelEstudo em AnimaisDorDor — AgudaAnandamida (AEA)Tetraidrocanabinol (THC)+2
  60. 2002

    Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study

    FavorávelEstudo em AnimaisEfeitos Adversos da Cannabis
  61. 2002

    Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial

    FavorávelEnsaio Clínico Duplo-CegoTraumatismo CranioencefálicoCanabinoides Sintéticos HU-x
  62. 2002

    Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat

    DesfavorávelEstudo em AnimaisDisfunção CognitivaSíndrome MetabólicaTranstornos de ComportamentoCanabinoides Sintéticos SR-x
  63. 2002

    Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study

    InconclusivoEnsaio ClínicoNáusea e VômitoTHC Farmacêutico
  64. 2002

    Endocannabinoids and related fatty acid derivatives in pain modulation

    FavorávelMetanáliseDorDor — CrônicaDor — AgudaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  65. 2002

    Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid

    FavorávelEstudo em AnimaisCâncerCâncer — TireoideHipertireoidismo e Doença de GravesCanabinoides Sintéticos WIN-xCanabinoides Sintéticos SR-x
  66. 2002

    Functional role for cannabinoids in respiratory stability during sleep.

    FavorávelEstudo em AnimaisApneia do SonoTetraidrocanabinol (THC)Outros Compostos Relacionados
  67. 2002

    International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

    InconclusivoMetanáliseEndocanabinoide (não especificado)Canabinoide Sintético (não especificado)
  68. 2002

    Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer

    DesfavorávelEnsaio ClínicoGestaçãoAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)
  69. 2002

    Motivational interviewing among psychiatric in-patients with substance use disorder

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Álcool+1
  70. 2002

    Nefazodone decreases anxiety during marijuana withdrawal in humans

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisAnsiedadeTetraidrocanabinol (THC)
  71. 2002

    Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues

    FavorávelEstudo LaboratorialAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  72. 2002

    Phytol, SSADH inhibitory diterpenoid of Lactuca sativa.

    FavorávelEstudo LaboratorialAnsiedade
  73. 2002

    Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease.

    FavorávelEnsaio ClínicoPruridoTetraidrocanabinol (THC)THC Farmacêutico
  74. 2002

    Prevention of vitamin A teratogenesis by phytol or phytanic acid results from reduced metabolism of retinol to the teratogenic metabolite, all-trans-retinoic acid.

    FavorávelEstudo LaboratorialTrabalho de Parto e Complicações
  75. 2002

    Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia

    InconclusivoEnsaio Clínico Duplo-CegoDistoniaTHC Farmacêutico
  76. 2002

    Reduced glial fibrillary acidic protein and glutamine synthetase expression in astrocytes and Bergmann glial cells in the rat cerebellum caused by delta(9)-tetrahydrocannabinol administration during development

    DesfavorávelEstudo em AnimaisGestaçãoAlterações Cerebrais Neonatais
  77. 2002

    Respiratory and immunologic consequences of marijuana smoking

    DesfavorávelMetanáliseCâncerCâncer — PulmãoBronquite
  78. 2002

    Safety, tolerability, and efficacy of orally administered cannabinoids in MS

    DesfavorávelEnsaio Clínico Duplo-CegoEsclerose Múltipla
  79. 2002

    Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients

    InconclusivoEnsaio Clínico Duplo-CegoHIV/AIDSTHC Farmacêutico
  80. 2002

    Specific induction of apoptosis by 1,8-cineole in two human leukemia cell lines, but not a in human stomach cancer cell line.

    FavorávelEstudo LaboratorialCâncerCâncer — Leucemia
  81. 2002

    SR141716, A Central Cannabinoid (CB(1)) Receptor Antagonist, Blocks The Motivational And Dopamine-releasing Effects Of Nicotine In Rats

    FavorávelEstudo em AnimaisDependência QuímicaDependência — ÁlcoolDependência — NicotinaCanabinoides Sintéticos SR-x
  82. 2002

    Survey on the Medical Use of Cannabis and THC in Germany.

    FavorávelMetanáliseDistúrbios Menstruais
  83. 2002

    Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

    FavorávelEstudo LaboratorialCâncerCâncer — LinfomaAnandamida (AEA)Tetraidrocanabinol (THC)+2
  84. 2002

    Tetrahydrocannabinol and endocannabinoids in feeding and appetite

    InconclusivoMetanáliseObesidadeAnorexia (perda de apetite)Perda de ApetiteTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  85. 2002

    The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells

    InconclusivoEstudo LaboratorialCâncerCâncer — Neuroblastoma
  86. 2002

    The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir

    InconclusivoEnsaio Clínico Duplo-CegoHIV/AIDSTHC Farmacêutico
  87. 2002

    The endogenous cannabinoid system controls extinction of aversive memories

    FavorávelEstudo em AnimaisTEPTCanabinoides Sintéticos SR-x
  88. 2002

    The palmitoylethanolamide family: a new class of anti-inflammatory agents?

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaAnandamida (AEA)Palmitoiletanolamida (PEA)+1
  89. 2002

    The Role of Endocannabinoids in the Hypothalamic Regulation of Visceral Function

    FavorávelMetanáliseEpilepsiaEpilepsia — FIRES
  90. 2002

    Δ9-Tetrahydrocannabinol and Cannabinol Activate Capsaicin-Sensitive Sensory Nerves via a CB1 and CB2 Cannabinoid Receptor-Independent Mechanism

    FavorávelEstudo LaboratorialDorTetraidrocanabinol (THC)Canabinol (CBN)+1
  91. 2001

    Absence of delta -9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice

    FavorávelEstudo em AnimaisDorDependência — OpioidesDor — AgudaTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  92. 2001

    An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

    FavorávelEstudo em AnimaisTraumatismo Cranioencefálico2-Araquidonoilglicerol (2-AG)
  93. 2001

    Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice.

    FavorávelEstudo em AnimaisEpilepsiaPalmitoiletanolamida (PEA)
  94. 2001

    Antiemetic efficacy of smoked marijuana: subjective and behavioral effects on nausea induced by syrup of ipecac

    InconclusivoEnsaio ClínicoNáusea e Vômito
  95. 2001

    Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

    DesfavorávelMetanálise ClínicaDor — CrônicaDor — AgudaDor — Oncológica
  96. 2001

    Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716

    FavorávelEnsaio ClínicoCanabinoides Sintéticos SR-x
  97. 2001

    Bupropion SR worsens mood during marijuana withdrawal in humans

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  98. 2001

    Cannabinoidergic and opioidergic inhibition of spinal reflexes in the decerebrated, spinalized rabbit

    FavorávelEstudo em AnimaisLesões da Medula EspinhalCanabinoides Sintéticos SR-xCanabinoides Sintéticos HU-x
  99. 2001

    Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.

    FavorávelMetanáliseNáusea e VômitoNáusea e Vômito por QuimioterapiaTetraidrocanabinol (THC)THC Farmacêutico+1
  100. 2001

    Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study

    FavorávelEnsaio Clínico Duplo-CegoDoença de ParkinsonDistoniaTHC Farmacêutico